Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis

Ziv Neeman, Steven K. Libutti, Jay W. Patti, Bradford J. Wood

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Portal vein thrombosis (PVT) may not be an absolute contraindication for hepatic radiofrequency ablation (RFA). Although the data are sparse, PVT is commonly considered a contraindication to RFA. PVT has actually been described as a complication following RFA. RFA was used to treat a 3.9×2.9 cm primary hepatocellular carcinoma (HCC) in a patient with concomitant PVT without complication. RFA can be safely performed in this setting but further studies could clarify this issue.

Original languageEnglish (US)
Pages (from-to)417-420
Number of pages4
JournalClinical Imaging
Volume27
Issue number6
DOIs
StatePublished - Nov 2003
Externally publishedYes

Fingerprint

Portal Vein
Hepatocellular Carcinoma
Thrombosis
Liver

Keywords

  • Hepatocellular carcinoma (HCC)
  • Portal vein thrombosis (PVT)
  • Radiofrequency ablation (RFA)

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis. / Neeman, Ziv; Libutti, Steven K.; Patti, Jay W.; Wood, Bradford J.

In: Clinical Imaging, Vol. 27, No. 6, 11.2003, p. 417-420.

Research output: Contribution to journalArticle

Neeman, Ziv ; Libutti, Steven K. ; Patti, Jay W. ; Wood, Bradford J. / Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis. In: Clinical Imaging. 2003 ; Vol. 27, No. 6. pp. 417-420.
@article{c71aa789b3eb4dbf82b07983dd870633,
title = "Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis",
abstract = "Portal vein thrombosis (PVT) may not be an absolute contraindication for hepatic radiofrequency ablation (RFA). Although the data are sparse, PVT is commonly considered a contraindication to RFA. PVT has actually been described as a complication following RFA. RFA was used to treat a 3.9×2.9 cm primary hepatocellular carcinoma (HCC) in a patient with concomitant PVT without complication. RFA can be safely performed in this setting but further studies could clarify this issue.",
keywords = "Hepatocellular carcinoma (HCC), Portal vein thrombosis (PVT), Radiofrequency ablation (RFA)",
author = "Ziv Neeman and Libutti, {Steven K.} and Patti, {Jay W.} and Wood, {Bradford J.}",
year = "2003",
month = "11",
doi = "10.1016/S0899-7071(03)00015-9",
language = "English (US)",
volume = "27",
pages = "417--420",
journal = "Clinical Imaging",
issn = "0899-7071",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis

AU - Neeman, Ziv

AU - Libutti, Steven K.

AU - Patti, Jay W.

AU - Wood, Bradford J.

PY - 2003/11

Y1 - 2003/11

N2 - Portal vein thrombosis (PVT) may not be an absolute contraindication for hepatic radiofrequency ablation (RFA). Although the data are sparse, PVT is commonly considered a contraindication to RFA. PVT has actually been described as a complication following RFA. RFA was used to treat a 3.9×2.9 cm primary hepatocellular carcinoma (HCC) in a patient with concomitant PVT without complication. RFA can be safely performed in this setting but further studies could clarify this issue.

AB - Portal vein thrombosis (PVT) may not be an absolute contraindication for hepatic radiofrequency ablation (RFA). Although the data are sparse, PVT is commonly considered a contraindication to RFA. PVT has actually been described as a complication following RFA. RFA was used to treat a 3.9×2.9 cm primary hepatocellular carcinoma (HCC) in a patient with concomitant PVT without complication. RFA can be safely performed in this setting but further studies could clarify this issue.

KW - Hepatocellular carcinoma (HCC)

KW - Portal vein thrombosis (PVT)

KW - Radiofrequency ablation (RFA)

UR - http://www.scopus.com/inward/record.url?scp=0142258082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142258082&partnerID=8YFLogxK

U2 - 10.1016/S0899-7071(03)00015-9

DO - 10.1016/S0899-7071(03)00015-9

M3 - Article

VL - 27

SP - 417

EP - 420

JO - Clinical Imaging

JF - Clinical Imaging

SN - 0899-7071

IS - 6

ER -